Evidence map›Paper›PMID 38803172›Full record

ReviewCurrent pharmaceutical biotechnology2025

Spirulina Unveiled: A Comprehensive Review on Biotechnological Innovations, Nutritional Proficiency, and Clinical Implications.

Ravi K Mittal, Gaurav Krishna, Vikram Sharma, Priyank Purohit, Raghav Mishra

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ravi K MittalGalgotias College of Pharmacy, Greater Noida, Uttar Pradesh, 201310, India.ORCID 0000-0001-8234-2466
Gaurav KrishnaDepartment of Pharmacy, GLA University, Mathura, 281406, Uttar Pradesh, India.ORCID 0000-0003-1398-9340
Vikram SharmaGalgotias College of Pharmacy, Greater Noida, Uttar Pradesh, 201310, India.ORCID 0000-0002-8655-7752
Priyank PurohitSchool of Pharmacy, Graphic Era Hill University, Dehradun, Uttarakhand, 248002, India.ORCID 0000-0002-1011-4736
Raghav MishraLloyd School of Pharmacy, Knowledge Park II, Greater Noida, Uttar Pradesh, 201306, India.ORCID 0000-0001-5269-2860

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This comprehensive review of Spirulina encompasses biotechnology, phycocyanin production, and purification. Bioactive compounds and vital nutrients were investigated during the study. The literature examines the potential therapeutic advantages and clinical applications of Spirulina. This analysis assesses Spirulina consumption and its associated health risks. The current review offers a comprehensive synthesis of the therapeutic applications as well as technologies utilized for the extraction and purification of phycocyanin. Moreover, this discourse delves into the examination of various advantageous techniques for extracting and purifying phycocyanin, encompassing physical, chemical, and enzymatic methods. The data derived from a multitude of studies strongly indicate the potential therapeutic applications of phycocyanin, encompassing its notable attributes as an antioxidant, anti-inflammatory agent, anticancer agent, antiviral agent, antimicrobial agent, antiallergic agent, anti-obesity agent, antihypertensive agent, and an immunological agent.

Indexed as

PhycocyaninSpirulinaAnimalsBiotechnologyHumansPhycocyaninalgaebiotechnological methodscyanobacteriafunctional foodsmedicinal usesphycocyanin.Spirulinasuperfood

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.